ஹெல்த் சயின்ஸ் ஜர்னல்

  • ஐ.எஸ்.எஸ்.என்: 1108-7366
  • ஜர்னல் எச்-இண்டெக்ஸ்: 51
  • ஜர்னல் மேற்கோள் மதிப்பெண்: 10.69
  • ஜர்னல் தாக்க காரணி: 9.13
குறியிடப்பட்டது
  • ஜெனமிக்ஸ் ஜர்னல்சீக்
  • சீனாவின் தேசிய அறிவு உள்கட்டமைப்பு (CNKI)
  • CiteFactor
  • CINAHL முழுமையானது
  • சிமாகோ
  • எலக்ட்ரானிக் ஜர்னல்ஸ் லைப்ரரி
  • டைரக்டரி ஆஃப் ரிசர்ச் ஜர்னல் இன்டெக்சிங் (DRJI)
  • EMCare
  • OCLC- WorldCat
  • பல்கலைக்கழக மானியக் குழு
  • மருத்துவக் கல்வி மற்றும் ஆராய்ச்சிக்கான ஜெனீவா அறக்கட்டளை
  • யூரோ பப்
  • கூகுள் ஸ்காலர்
  • ஷெர்பா ரோமியோ
  • ரகசிய தேடுபொறி ஆய்வகங்கள்
இந்தப் பக்கத்தைப் பகிரவும்

சுருக்கம்

Assessment of Prenatal Iron + Folic Acid Supplementation and Utilization among Pregnant Women at Anc Clinic in Kirkose Subcity Health Center Addis Ababa, Ethiopia

Haymanot Jenberu* and Cheru Kore

Background: Globally 41.8% of pregnant women are anemic with the highest proportion affected in developing countries. Nationally only 0.4% of the pregnant women take Iron supplements quite 90 days of the recommended 180 days. In oromiya region 75.3% of pregnant women don't take any iron tablets or syrup during their last pregnancy, while 10.8% deem but 60 days, 0.4% takes for 60-89 days and only 0.3% takes for 90 days or more.

Objective: To Assess prenatal Iron + folic acid supplementation and utilization among pregnant women attending ANC clinic in Kirkose Sub city, Addis Ababa, Ethiopia.

Methods: Institution based cross-sectional quantitative study design was conducted in Kirkose Sub city from June 2021 to July, 2021.There was seven health centers selected for this study. The sample size 317 was selected with systematic sampling method. Five percent of the sample size was pre-tested in one institution which was not included for data collection. Data was collected using structured pre-tested questionnaire. Before data collection verbal consent was obtained. The collected data was analyzed SPSS version 20.0 packages to show the magnitude of prenatal folic acid utilization and supplementation.

Result: A total of eligible 317 study population, 287 were successfully participated with a response rate of approximately 90.5%. The study participants had a mean age of 27.4 years. The magnitude of iron-folic acid supplementation was found to be 231(80.5%). Among the respondents who took IFA they replied 20(8.65%) took for a month duration, 62(26.8%) took for two months, 84(36.3%) of them took for three months and the rest 65(28.1%) took for more than three months.

Conclusion: Even if the magnitude iron-folic acid supplementation was high in this study, there was still low utilization among pregnant women.